Sonic Healthcare (ASX:SHL) Long-Term Debt: A$5,116 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:SHL Sonic Healthcare Ltd ASX:SHL
81 GF Score
Price A$21.74
GF Value A$33.06
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is Sonic Healthcare Long-Term Debt?

Sonic Healthcare ASX:SHL +1.21% 81 Long-Term Debt is A$5,116 Mil as of Dec. 2025. GuruFocus rates ASX:SHL with a GF Score™ of 81/100 and a GF Value™ of A$33.06 (Significantly Undervalued). The stock has 5 warning signs investors should review.

Sonic Healthcare's Long-Term Debt for the quarter that ended in Dec. 2025 was A$5,116 Mil.

Sonic Healthcare's quarterly Long-Term Debt declined from Dec. 2024 (A$4,188 Mil) to Jun. 2025 (A$3,408 Mil) but then increased from Jun. 2025 (A$3,408 Mil) to Dec. 2025 (A$5,116 Mil).

Sonic Healthcare's annual Long-Term Debt increased from Jun. 2023 (A$3,347 Mil) to Jun. 2024 (A$5,381 Mil) but then declined from Jun. 2024 (A$5,381 Mil) to Jun. 2025 (A$3,408 Mil).

Sonic Healthcare  (ASX:SHL) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Sonic Healthcare Long-Term Debt Related Terms

Sonic Healthcare Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Sonic Healthcare's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sonic Healthcare Long-Term Debt Chart

Sonic Healthcare Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,184.76 3,153.87 3,346.92 5,380.80 3,408.43

Sonic Healthcare Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,188.80 5,380.80 4,187.73 3,408.43 5,115.65
ASX:SHL
81GF Score
Sonic Healthcare Ltd ASX:SHL
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of A$5,116 Mil mean?
Sonic Healthcare (ASX:SHL) has a Long-Term Debt of A$5,116 Mil as of Dec. 2025.
Is Sonic Healthcare's Long-Term Debt too high?
Sonic Healthcare's current Long-Term Debt is A$5,116 Mil. Overall, Sonic Healthcare has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sonic Healthcare's Long-Term Debt compare to TMO and DHR?
Sonic Healthcare's Long-Term Debt of A$5,116 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Diagnostics & Research company?
A good Long-Term Debt depends on the Medical Diagnostics & Research industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Sonic Healthcare's current Long-Term Debt is A$5,116 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sonic Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sonic Healthcare (ASX:SHL) is currently considered Significantly Undervalued. The stock's GF Value™ is A$33.06, compared to a current price of A$21.74 — trading 34.2% below its estimated fair value. The current Long-Term Debt is A$5,116 Mil. Sonic Healthcare's overall GF Score™ is 81/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Sonic Healthcare (ASX:SHL), the current Long-Term Debt is A$5,116 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sonic Healthcare (ASX:SHL) Overvalued in 2026?

Based on GuruFocus' analysis, Sonic Healthcare stock appears to be undervalued. The current stock price of A$21.74 is trading 34.2% below its estimated GF Value™ of A$33.06. GuruFocus considers Sonic Healthcare to be Significantly Undervalued.

Key valuation signals for ASX:SHL:

  • Long-Term Debt: A$5,116 Mil
  • GF Value™: A$33.06 vs. price of A$21.74 (34.2% below fair value)
  • GF Score™: 81/100 with 5 warning signs

No single metric tells the full story. See the ASX:SHL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sonic Healthcare Business Description

Address 225 George Street, Level 22, Grosvenor Place, Sydney, NSW, AUS, 2000
Sonic Healthcare is a global pathology provider. It is the largest private operator in Australia, Germany, Switzerland and the UK, the second-largest in Belgium and New Zealand, and the third largest in the US. In addition to pathology, which contributes roughly 85% of group revenue, Sonic is the second-largest player in diagnostic imaging in Australia and the largest operator of medical centers in Australia. The company typically earns about 35% of group revenue in Australia and New Zealand, 25% in the US, and 40% in Europe.
81GF Score

Get the complete analysis for ASX:SHL

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$21.74
Price
A$33.06
GF Value